The E3 ubiquitin ligase human murine double minute (HDM2) is overexpressed in 40%–80% of late-stage metastatic cancers in the absence of gene amplification. Hdm2 regulates p53 stability via ubiquitination and has also been implicated in altering the sensitivity of cells to TGF-β1. Whether TGF-β1 signaling induces Hdm2 expression leading to HDM2-mediated destabilization of p53 has not been investigated. In this study, we report that TGF-β1–activated SMA- and MAD3 (Smad3/4) transcription factors specifically bound to the second promoter region of HDM2, leading to increased HDM2 protein expression and destabilization of p53 in human cancer cell lines. Additionally, TGF-β1 expression led to Smad3 activation and murine double minute 2 (Mdm2) expression in murine mammary epithelial cells during epithelial-to-mesenchymal transition (EMT). Furthermore, histological analyses of human breast cancer samples demonstrated that approximately 65% of late-stage carcinomas were positive for activated Smad3 and HDM2, indicating a strong correlation between TGF-β1–mediated induction of HDM2 and late-stage tumor progression. Identification of Hdm2 as a downstream target of TGF-β1 represents a critical prosurvival mechanism in cancer progression and provides another point for therapeutic intervention in late-stage cancer.
Shinako Araki, Jacob A. Eitel, Christopher N. Batuello, Khadijeh Bijangi-Vishehsaraei, Xian-Jin Xie, David Danielpour, Karen E. Pollok, David A. Boothman, Lindsey D. Mayo
Title and authors | Publication | Year |
---|---|---|
FoxM1 sustains the Smad3/4 complex and controls transforming growth factor-β signaling and cancer metastasis
Jianfei Xue, Xia Lin, Wen-Tai Chiu, Yao-Hui Chen, Guanzhen Yu, Mingguang Liu, Xin-Hua Feng, Raymond Sawaya, Rene Medema, Mien-Chie Hung, Suyun Huang |
Journal of Clinical Investigation | 2014 |
Masking Epistasis Between MYC and TGF-β Pathways in Antiangiogenesis-Mediated Colon Cancer Suppression
M Dews, GS Tan, S Hultine, P Raman, J Choi, EK Duperret, J Lawler, A Bass, A Thomas-Tikhonenko |
JNCI Journal of the National Cancer Institute | 2014 |
Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition
L Jiang, L Xiao, H Sugiura, X Huang, A Ali, M Kuro-o, RJ Deberardinis, DA Boothman |
Oncogene | 2014 |
Tumor suppression in skin and other tissues via cross-talk between vitamin D- and p53-signaling
JÃ Reichrath, S Reichrath, K Heyne, T Vogt, K Roemer |
Frontiers in physiology | 2014 |
TP53 supports basal-like differentiation of mammary epithelial cells by preventing translocation of deltaNp63 into nucleoli
PM Munne, Y Gu, M Tumiati, P Gao, S Koopal, S Uusivirta, J Sawicki, GH Wei, SG Kuznetsov |
Scientific Reports | 2014 |
Differential expression of centrosome regulators in Her2+ breast cancer cells versus non-tumorigenic MCF10A cells
MY Lee, M Marina, JL King, HI Saavedra |
Cell division | 2014 |
Axl as a downstream effector of TGF-β1 via PI3K/Akt-PAK1 signaling pathway promotes tumor invasion and chemoresistance in breast carcinoma
Y Li, L Jia, C Liu, Y Gong, D Ren, N Wang, X Zhang, Y Zhao |
Tumor Biology | 2014 |
TSPAN12 is a critical factor for cancer–fibroblast cell contact-mediated cancer invasion
R Otomo, C Otsubo, Y Matsushima-Hibiya, M Miyazaki, F Tashiro, H Ichikawa, T Kohno, T Ochiya, J Yokota, H Nakagama, Y Taya, M Enari |
Proceedings of the National Academy of Sciences | 2014 |
The MDM2 gene family
M Mendoza, G Mandani, J Momand |
BioMolecular Concepts | 2014 |
Targeting MDM2-p53 interaction for cancer therapy: are we there yet?
Nag S, Zhang X, Srivenugopal KS, Wang MH, Wang W, Zhang R |
Current medicinal chemistry | 2014 |